Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC

Autor: Ismail, R K, Schramel, F M N H, van Dartel, M, Pasmooij, A M G, Cramer-van der Welle, C M, Hilarius, D L, de Boer, A, Wouters, M W J M, van de Garde, E M W

BACKGROUND: Many studies have compared real-world clinical outcomes of immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC) with reported outcomes data from pivotal trials. However, any differences observed could be only limit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______101::2fb39bb1e0c50050e1b197b12b9a7f5d
https://dspace.library.uu.nl/handle/1874/426661

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients

Autor: Ismail, R. K., Schramel, F. M.N.H., van Dartel, M., Hilarius, D. L., de Boer, A., Wouters, M. W.J.M., Smit, H. J.M., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Lung Cancer, 149, 68. Elsevier Ireland Ltd.
Lung Cancer, 149, 68-77. ELSEVIER IRELAND LTD

Objectives This study describes the initiation of the Dutch Lung Cancer Audit for Lung Oncology (DLCA-L) and reports the first results of three years of clinical auditing. Methods The initiation, dataset, and data quality of the DLCA-L are described.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f6002278ac9a6eaaffc08209915684
https://doi.org/10.1016/j.lungcan.2020.08.011

Real-world outcomes of advanced melanoma patients not represented in phase III trials

Autor: van Zeijl, M C T, Ismail, R K, de Wreede, L C, van den Eertwegh, A J M, de Boer, A, van Dartel, M, Hilarius, D L, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Haanen, J B A G, Wouters, M W J M, Sub Algemeen Math. Inst, Afd Pharmacoepi & Clinical Pharmacology, extern UU GWS, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: International Journal of Cancer, 147(12), 3461-3470. Wiley-Liss Inc.
International Journal of Cancer
van Zeijl, M C T, Ismail, R K, de Wreede, L C, van den Eertwegh, A J M, de Boer, A, van Dartel, M, Hilarius, D L, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Haanen, J B A G & Wouters, M W J M 2020, ' Real-world outcomes of advanced melanoma patients not represented in phase III trials ', International Journal of Cancer, vol. 147, no. 12, pp. 3461-3470 . https://doi.org/10.1002/ijc.33162
International Journal of Cancer, 147(12), 3461. Wiley-Liss Inc.
International Journal of Cancer, 147, 3461-3470
International Journal of Cancer, 147, 12, pp. 3461-3470
International Journal of Cancer, 147(12), 3461-3470. Wiley
International Journal of Cancer, 147(12), 3461-3470. WILEY

The aim was to provide evidence on systemically treated patients with advanced melanoma not represented in phase III trials to support clinical decision‐making. Analysis were performed on advanced melanoma patients diagnosed between 2014 and 2017 i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed76ac9413719b51176ab36de68bd351
https://dspace.library.uu.nl/handle/1874/408494

1081P Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients: Nation-wide quality assurance in the Netherlands

Autor: Breeschoten, J.V., Van den Eertwegh, A.J.M., de Wreede, L., Hilarius, D., van Zwet, E., Haanen, J.B.A.G., Blank, C.U., Aarts, M., Van den Berkmortel, F., de Groot, J.W.B., Hospers, G.A., Kapiteijn, E., Piersma, D., van Rijn, R.S., Stevense, M., Van der Veldt, A.A.M., Vreugdenhil, G., Boers-Sonderen, M., Suijkerbuijk, K., Wouters, M.W.J.M.

Publikováno v: In Annals of Oncology September 2021 32 Supplement 5:S896-S896